ArticleThe oncologist2021

Novel SLC12A2-ROS1 Fusion in Non-Small Cell Lung Cancer with a Significant Response to Crizotinib: The Importance of Choosing the Appropriate Next-Generation Sequencing Assay.

Carlos Rodríguez-Antolín et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.